https://knews.kathimerini.com.cy/en/news/booster-shots-begin-for-people-50-and-over
Following the decision of the Council of Ministers yesterday regarding COVID-19 booster shots for vulnerable citizens and those aged 50 and over, the Health Ministry announces the following:...
https://knews.kathimerini.com.cy/en/news/possible-cyber-attack-on-the-gesy-portal
A fake email entitled "GESY: Third dose of COVID-19 mRNA vaccine" is reportedly being sent to people in Cyprus showing GESY as the sender, according to the Health Insurance Agency....
https://knews.kathimerini.com.cy/en/news/no-side-effects-from-vaccine-mix-and-match
No side effects have been recorded in Cyprus from the mixing of different vaccines, according to Dr. Elena Panagiotopoulou,...
https://knews.kathimerini.com.cy/en/news/new-types-of-covid-vaccines-and-alternative-therapies
It's only a matter of time before Cyprus finalizes orders of new COVID vaccines and therapies. ...
https://knews.kathimerini.com.cy/en/news/swedish-research-high-efficacy-with-a-combination-of-vaccines
Another study, this time Swedish, shows that combining different vaccines against coronavirus is highly effective in terms of immune protection....
https://knews.kathimerini.com.cy/en/news/cancer-vaccines-in-two-to-three-years
Drs. Ugur Sahin and Ozlem Tureci are a very modest, perhaps even humble, scientist couple. ...
https://knews.kathimerini.com.cy/en/news/johnson-johnson-vaccine-is-a-booster-shot-necessary
The New York Times answers questions about J&J booster shots...
https://knews.kathimerini.com.cy/en/life/vaccination-of-children-adolescents-answers-to-commonly-asked-questions
Here are the most commonly asked questions and answers about the COVID-19 vaccine provided by the National Vaccination Committee....
https://knews.kathimerini.com.cy/en/life/are-covid-boosters-needed
Advisers to the U.S. Food and Drug Administration are expected to discuss whether boosters will help....
https://knews.kathimerini.com.cy/en/news/cypriot-experts-on-board-with-third-dose
The Cypriot government will take a political decision this week on a proposal to start administering third COVID-19 vaccine doses ahead of the flu season in response to the Delta variant threat that emerged sooner than expected during the summer...
https://knews.kathimerini.com.cy/en/news/booster-shot-up-in-the-air-as-cyprus-vaccinates
Cyprus is very close to having 70% of eligible adults fully vaccinated, but debate on what’s next such as a booster shot is far from over as Israel gets unexpected data and WHO warns against an 'ill-advised' third dose...
https://knews.kathimerini.com.cy/en/news/cypriot-government-toughens-safe-pass-rules
The Cabinet announced on Friday that new pandemic rules will apply on Monday, including a greater number of shops out of reach for people without a Safe Pass and follow up rapid or PCR tests checks for foreign visitors who are not vaccinated...
https://knews.kathimerini.com.cy/en/news/president-tells-youth-unvaccinated-ain-t-cool
Daily COVID cases rose to 314 on Monday in the Republic of Cyprus, with President Nicos Anastasiades calling vaccinations 'patriotic duty' and reminding the youth is not invulnerable...
https://knews.kathimerini.com.cy/en/news/cyprus-adopts-restrictions-for-astrazeneca
The Republic of Cyprus is adopting age restrictions for the AstraZeneca vaccine, following a fatal blood clot incident and intense debate amongst health experts, with the decision coming just hours after the health minister had warned he would seek answers abroad if the advisory team failed to deliver a solid recommendation...
https://knews.kathimerini.com.cy/en/news/moderna-to-seek-us-eu-authorization-for-vaccine-on-monday
Moderna Inc will apply for US and European emergency authorization for its Covid-19 vaccine on Monday after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns, the company said....
https://knews.kathimerini.com.cy/en/news/eu-could-pay-over-$10-billion-for-pfizer-and-curevac-vaccines
The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters....
https://knews.kathimerini.com.cy/en/news/pfizer-ends-covid-19-trial-with-95-efficacy
Pfizer Inc said on Wednesday that final results from the late-stage trial of its Covid-19 vaccine show it was 95% effective, adding it had the required two-months of safety data and would apply for emergency US authorization within days....
https://knews.kathimerini.com.cy/en/news/moderna-s-coronavirus-vaccine-nearly-95-effective-early-data-shows
For the second time this month, there’s promising news from a Covid-19 vaccine candidate: Moderna said Monday its shots provide strong protection, a dash of hope against the grim backdrop of coronavirus surges in the US and around the world.
...
https://knews.kathimerini.com.cy/en/news/pfizer-biontech-say-their-covid-19-vaccine-is-more-than-90-effective
Pfizer Inc on Monday said its experimental vaccine was more than 90% effective in preventing Covid-19 based on initial data from a large study, a major victory in the fight against a pandemic that has killed over 1 million people, roiled the world’s economy and upended daily life....
https://knews.kathimerini.com.cy/en/news/eu-keeps-expanding-future-vaccine-portfolio
EU Health Commissioner Stella Kyriakides said the European Commission has concluded exploratory talks with CureVac to purchase a potential vaccine against COVID-19...
